Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

(2014) Kenneth R. Carson et al.   CANCER

Treating Progressive Multifocal Leukoencephalopathy With Interleukin 7 and Vaccination With JC Virus Capsid Protein VP1

(2014) Mireia Sospedra et al.   CLINICAL INFECTIOUS DISEASES

JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection

(2014) Melissa S. Maginnis et al.   JOURNAL OF NEUROVIROLOGY

Maraviroc and JC Virus–Associated Immune Reconstitution Inflammatory Syndrome

(2014) Paul S. Giacomini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Viral miRNAs in plasma and urine divulge JC polyomavirus infection

(2014) Ole Lagatie et al.   Virology Journal

Treatment of Progressive Multifocal Leukoencephalopathy With Interleukin 7

(2014) Karl B. Alstadhaug et al.   JAMA Neurology

Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy

(2014) J. Gasnault et al.   Open Forum Infectious Diseases

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

(2013) Stefanie Dahlhaus et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

(2013) David B. Clifford et al.   JOURNAL OF NEUROVIROLOGY

A Retrograde Trafficking Inhibitor of Ricin and Shiga-Like Toxins Inhibits Infection of Cells by Human and Monkey Polyomaviruses

(2013) C. D. S. Nelson et al.   mBio

Immunosuppression Increases JC Polyomavirus Large T Antigen DNA Load in the Brains of Patients Without Progressive Multifocal Leukoencephalopathy

(2012) Julianne Bayliss et al.   JOURNAL OF INFECTIOUS DISEASES

Suppressive effect of PARP-1 inhibitor on JC virus replication in vitro

(2012) Souichi Nukuzuma et al.   JOURNAL OF MEDICAL VIROLOGY

Disease-modifying drugs for multiple sclerosis and JC virus expression

(2012) Craig S. Miller et al.   JOURNAL OF NEUROVIROLOGY

PML-IRIS in a patient treated with brentuximab

(2012) G. von Geldern et al.   NEUROLOGY

Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?

(2012) C. Antoniol et al.   NEUROLOGY

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

(2012) Ran Reshef et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry

(2012) Christian D.S. Nelson et al.   VIROLOGY

CMX001 (1-O-Hexadecyloxypropyl-Cidofovir) Inhibits Polyomavirus JC Replication in Human Brain Progenitor-Derived Astrocytes

(2011) Rainer Gosert et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

(2011) David B. Clifford   ARCHIVES OF NEUROLOGY

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy: Figure 1

(2011) Rémy Phan-Ba et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Immunological and clinical consequences of treating a patient with natalizumab

(2011) Nicholas Schwab et al.   Multiple Sclerosis Journal

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

(2011) I. L. Tan et al.   NEUROLOGY

Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy

(2011) Jacques Gasnault et al.   PLoS One

Hexadecyloxypropyl-Cidofovir (CMX001) Suppresses JC Virus Replication in Human Fetal Brain SVG Cell Cultures

(2010) Z.-G. Jiang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient

(2010) A Balduzzi et al.   BONE MARROW TRANSPLANTATION

A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia

(2010) A. Patel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Characterization of JC human polyomavirus infection in a Portuguese population

(2010) Ana Matos et al.   JOURNAL OF MEDICAL VIROLOGY

JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal Leukoencephalopathy

(2010) C. S. Tan et al.   JOURNAL OF VIROLOGY

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

(2010) Chen S Tan et al.   LANCET NEUROLOGY

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

(2010) Bruce J. Brew et al.   Nature Reviews Neurology

Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro

(2009) M. Brickelmaier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy

(2009) Deanna Cettomai et al.   ARCHIVES OF NEUROLOGY

Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases

(2009) Eamonn S. Molloy et al.   ARTHRITIS AND RHEUMATISM

Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study

(2009) Nina Khanna et al.   CLINICAL INFECTIOUS DISEASES

Leflunomide Inhibition of BK Virus Replication in Renal Tubular Epithelial Cells

(2009) E. Bernhoff et al.   JOURNAL OF VIROLOGY

Progressive multifocal leukoencephalopathy in HIV-1 infection

(2009) Paola Cinque et al.   LANCET INFECTIOUS DISEASES

JCV vaccination could reduce the risk of developing cognitive decline, dementia, strokes and brain tumours, by preventing chronic JCV cerebral infection, and recurrent reactivation

(2009) Stephen Katona   MEDICAL HYPOTHESES

PML-IRIS in patients with HIV infection: Clinical manifestations and treatment with steroids

(2009) K. Tan et al.   NEUROLOGY

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

(2008) Andrea De Luca et al.   AIDS

Cidofovir Inhibits Polyomavirus BK Replication in Human Renal Tubular Cells Downstream of Viral Early Gene Expression

(2008) E. Bernhoff et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states

(2008) Jelle L. Epker et al.   European Journal of Internal Medicine

Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study

(2008) Frederik Neess Engsig et al.   JOURNAL OF INFECTIOUS DISEASES

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

(2008) Moti L Chapagain et al.   JOURNAL OF NEUROVIROLOGY

An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice

(2008) Tomoko Matoba et al.   NEUROPATHOLOGY

Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney Transplantation

(2008) Robert T. Neff et al.   TRANSPLANTATION